脐尿管癌诊断与治疗的研究进展  

Progress in the diagnosis and treatment of urachal carcinoma

作　　者：崔玉双 曹煜东 王硕[1] 杜鹏[1] Cui Yushuang;Cao Yudong;Wang Shuo;Du Peng(Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Urology,Peking University Cancer Hospital,Beijing 100142,China)

机构地区：[1]北京大学肿瘤医院暨北京市肿瘤防治研究所泌尿外科、恶性肿瘤发病机制及转化研究教育部重点实验室,北京100142

出　　处：《中华泌尿外科杂志》2024年第9期722-724,共3页Chinese Journal of Urology

摘　　要：脐尿管癌是一种罕见的泌尿系统恶性肿瘤,其早期症状不明显,诊断时多处于中晚期,预后较差。目前针对脐尿管癌的手术治疗以膀胱部分切除术+完整的脐部与脐尿管切除±盆腔淋巴结清扫为首选,其中90%以上的脐尿管癌术后病理证实为腺癌。而系统治疗则多参考膀胱腺癌或结直肠腺癌的治疗方案。本文整理近年来国内外脐尿管癌相关研究,对脐尿管癌的发病情况、临床特征、诊断以及治疗进行综述。Urachal carcinoma(UrC)is a rare urological malignancy.UrC is not obvious in its early symptoms,and is mostly in the advanced stage at diagnosis,with a poor prognosis.Surgical treatment was preferred by partial cystectomy+resection of complete umbilical and umbilical urinary catheter±pelvic lymph node dissection,and more than 90%of UrC were confirmed as adenocarcinoma through postoperative pathology.Systemic treatment is often based on treatment protocols for bladder adenocarcinoma or colorectal adenocarcinoma.This article reviews recent domestic and international research on UrC,summarizing its incidence,clinical characteristics,diagnosis,and treatment.

关 键 词：脐尿管癌 膀胱腺癌 化疗 免疫治疗 膀胱部分切除术 

分 类 号：R737.1[医药卫生—肿瘤]